DDD Partners LLC lifted its position in shares of Vicarious Surgical Inc. (NYSE:RBOT - Free Report) by 15.3% in the 1st quarter, according to its most recent 13F filing with the SEC. The firm owned 213,824 shares of the company's stock after acquiring an additional 28,357 shares during the quarter. DDD Partners LLC owned approximately 3.61% of Vicarious Surgical worth $1,403,000 at the end of the most recent quarter.
Other institutional investors and hedge funds also recently made changes to their positions in the company. DnB Asset Management AS boosted its stake in Vicarious Surgical by 21.1% in the 4th quarter. DnB Asset Management AS now owns 21,213 shares of the company's stock worth $279,000 after purchasing an additional 3,692 shares during the period. Geode Capital Management LLC boosted its stake in Vicarious Surgical by 8.2% in the 4th quarter. Geode Capital Management LLC now owns 30,799 shares of the company's stock worth $405,000 after purchasing an additional 2,336 shares during the period. Finally, Renaissance Technologies LLC boosted its stake in Vicarious Surgical by 11.6% in the 4th quarter. Renaissance Technologies LLC now owns 11,534 shares of the company's stock worth $152,000 after purchasing an additional 1,200 shares during the period. Institutional investors own 47.27% of the company's stock.
Vicarious Surgical Stock Performance
NYSE RBOT traded up $0.27 during trading hours on Friday, hitting $10.31. The company had a trading volume of 11,875 shares, compared to its average volume of 28,865. Vicarious Surgical Inc. has a 52 week low of $4.27 and a 52 week high of $19.00. The firm has a 50 day simple moving average of $7.94 and a 200 day simple moving average of $9.44. The firm has a market capitalization of $61.11 million, a price-to-earnings ratio of -0.99 and a beta of 1.40.
Vicarious Surgical (NYSE:RBOT - Get Free Report) last issued its quarterly earnings results on Monday, May 12th. The company reported ($2.58) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($2.61) by $0.03. On average, research analysts forecast that Vicarious Surgical Inc. will post -10.89 earnings per share for the current year.
About Vicarious Surgical
(
Free Report)
Vicarious Surgical Inc operates as a robotics technology company in the United States. The company focuses on developing and commercializing Vicarious System, a single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. Vicarious Surgical Inc was incorporated in 2014 and is headquartered in Waltham, Massachusetts.
Further Reading
Before you consider Vicarious Surgical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Vicarious Surgical wasn't on the list.
While Vicarious Surgical currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
